ERBB2 and breast cancer: The intersection of the two datasets manifested 2 potential targets for HER2-positive breast cancer, zinc finger and BTB/POZ domain-containing family protein 16 (ZBTB16) and promyelocytic leukemia protein (PML), which are known as essential tumor suppressors (Fig. 4d).